Clinical Trials Browser

Terminated × Brain Neoplasms × Ferrosoferric Oxide × Clear all

NCT00659126 2023-09-07

Ferumoxytol- and Gadolinium-Labeled MRI in Measuring Tumors Before or After Treatment in Patients With Primary or Metastatic Brain Tumors

Phase 2 Terminated

40 enrolled 8 charts

Brain Neoplasms